Edap Tms S.A. (EDAP) 3.30 $EDAP EDAP TMS' (EDAP) CEO

Edap Tms S.A. (EDAP) 3.30 $EDAP

EDAP TMS' (EDAP) CEO Marc Oczachowski on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Apr 02, 10:53AM CDT

EDAP: 3.30 (-0.07)

EDAP TMS S.A. (EDAP) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Apr 02, 7:25AM CDT

EDAP: 3.30 (-0.07)

EDAP net loss improves in FY14
Seeking Alpha - at Seeking Alpha - Thu Apr 02, 5:40AM CDT

EDAP: 3.30 (-0.07)

After Hours Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Apr 01, 4:39PM CDT

RIOM: 2.63 (+0.16), SNTA: 2.69 (-0.28), EDAP: 3.30 (-0.07), BPL: 79.75 (+0.62), CNAT: 6.66 (-0.15), AMAT: 21.80 (-0.37), GFI: 4.10 (-0.19), XON: 44.10 (-0.91), TCPI: 3.86 (-0.07), GSAT: 3.15 (+0.02)

EDAP TMS S.A. reports Q4 results
Seeking Alpha - at Seeking Alpha - Wed Apr 01, 3:25PM CDT

EDAP: 3.30 (-0.07)

EDAP Reports Fourth Quarter and Full Year 2014 Results
GlobeNewswire - Wed Apr 01, 3:20PM CDT
2014 and Recent Operational Highlights
EDAP: 3.30 (-0.07)

EDAP Announces Sale of First Focal One(R) HIFU Device in North America
GlobeNewswire - Tue Mar 31, 7:30AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first sale of Focal One HIFU device to Jewish General Hospital, Montreal, Canada. This sale occurs only two months after the Company gained Health Canada's approval to market its Focal One HIFU device for focal treatment of prostate cancer.
EDAP: 3.30 (-0.07)

EDAP to Participate in Major, Multi-Partner Liver Cancer Development Project
GlobeNewswire - Thu Mar 26, 3:05PM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the Company's participation in a major collaborative liver cancer project aimed at developing innovative new therapies for this prevalent indication.
EDAP: 3.30 (-0.07)

EDAP to Report Fourth Quarter and Full-Year 2014 Results on April 2, 2015
GlobeNewswire - Tue Mar 17, 7:30AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it plans to release financial results for the fourth quarter and year ended December 31, 2014 on Thursday, April 2, 2015, during pre-market hours.
EDAP: 3.30 (-0.07)

EDAP Announces Plans to Pursue Direct De Novo 510(k) Petition in Lieu of PMA for Its Ablatherm HIFU
GlobeNewswire - Mon Mar 09, 7:30AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that, based on a recent meeting with the U.S. Food and Drug Administration ("FDA", the Company plans to seek clearance of Ablatherm HIFU by way of a Direct De Novo 510(k) application as opposed to the Pre-Market Approval ("PMA" application amendment EDAP had been pursuing.
EDAP: 3.30 (-0.07)

The Top ADRs To Buy This Week
Todd Campbell - at Seeking Alpha - Thu Feb 12, 6:40AM CST

RUK: 67.76 (-0.33), BUD: 123.72 (+1.22), ANW: 15.38 (-0.15), DEG: 22.17 (-0.10), ENL: 48.94 (-0.31), FBR: 14.69 (+0.09), SNE: 31.34 (+0.62), TM: 141.21 (+0.18), RDY: 55.55 (-0.83), LUX: 64.88 (+0.48), OMAB: 41.25 (-0.19), TTM: 42.11 (+0.35), SNN: 35.76 (+0.44), RYAAY: 67.00 (+0.51), EDAP: 3.30 (-0.07), AZN: 71.79 (-1.34), TRIB: 17.18 (+0.02), EFA: 67.40 (+0.39), WX: 39.62 (+0.26), TEVA: 64.41 (+1.16)

Securities Lending Notable Names: JCP, AMBA
Interactive Brokers - at Seeking Alpha - Tue Jan 13, 2:32AM CST
Strong sales guidance gave some life to struggling department store operator, J.C. Penney Co., Inc. (NYSE: JCP ) last week following a prolonged period of negative news. The stock soared approximately 17% on Tuesday of last week after the company...
AMBA: 72.13 (-1.32), GPRO: 44.73 (-1.35), EDAP: 3.30 (-0.07), LNCO: 12.13 (-0.24), IMRS: 0.69 (+0.04), GALT: 3.29 (-0.04), JCP: 8.41 (-0.07), MOC: 1.92 (+0.02), BIND: 6.84 (-0.33), LINE: 13.56 (-0.05), JOB: 0.83 (+0.01), BCLI: 4.14 (+0.02), NDRM: 13.61 (-0.14)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Jan 09, 11:47AM CST

EOPN: 8.59 (unch), ADHD: 5.90 (+0.07), CNAT: 6.66 (-0.15), ADMP: 4.83 (+0.07), FIVE: 36.04 (+0.10), TESO: 12.59 (-0.24), ALXA: 1.94 (-0.06), PRTO: 12.30 (+0.01), AGEN: 7.12 (+0.75), ARGS: 8.56 (-0.18), TOPS: 1.13 (-0.03), HILL: 6.56 (+0.06), EDAP: 3.30 (-0.07), CTSO: 7.52 (+0.50), VLCCF: 5.00 (unch), SCYX: 9.47 (-0.52), VIMC: 14.01 (+0.75), SBLK: 3.87 (unch), DCTH: 1.04 (unch), IDN: 1.63 (unch)

EDAP up big on Canadian approval
Seeking Alpha - at Seeking Alpha - Fri Jan 09, 9:10AM CST

EDAP: 3.30 (-0.07)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Jan 09, 8:10AM CST

SD: 1.84 (unch), PTLA: 38.51 (-0.85), EOPN: 8.59 (unch), CNAT: 6.66 (-0.15), ADMP: 4.83 (+0.07), INFY: 31.81 (-3.15), FIVE: 36.04 (+0.10), AGEN: 7.12 (+0.75), SAN: 7.26 (+0.14), EDAP: 3.30 (-0.07), GMLP: 28.04 (+0.08), CTSO: 7.52 (+0.50), SBLK: 3.87 (unch), IDN: 1.63 (unch)

EDAP's Focal One HIFU Device Approved by Health Canada
GlobeNewswire - Fri Jan 09, 7:40AM CST
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that its Focal One HIFU device has been approved by Health Canada. With this approval, the Company is able to market the Focal One device for the treatment of prostate cancer in Canada.
EDAP: 3.30 (-0.07)

EDAP gets a boost after earnings report
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 11:27AM CST

EDAP: 3.30 (-0.07)